C. Franke

发表

A COMPARATIVE SAR AND COMPUTER MODELING STUDY OF BENZISOTHIAZOLONE, MECHANISM-BASED INHIBITORS WITH PORCINE PANCREATIC AND HUMAN LEUKOCYTE ELASTASE

D. Hlasta, J. Court, Jian Shen, 1996 .

The design of potent and stable benzisothiazolone inhibitors of human leukocyte elastase

R. Gordon, A. Rowlands, D. Hlasta, 1995 .

Pulmonary Hemorrhage Induced by Intratracheal Administration of Human Leukocyte Elastase in Hamsters

R. Gordon, P. Silver, E. Ferguson, 1991, Annals of the New York Academy of Sciences.

A novel class of cyclic beta-dicarbonyl leaving groups and their use in the design of benzisothiazolone human leukocyte elastase inhibitors.

J. Kofron, D. Hlasta, R. P. Farrell, 1995, Journal of Medicinal Chemistry.

A Novel Class of Cyclic β‐Dicarbonyl Leaving Groups and Their Use in the Design of Benzisothiazolone Human Leukocyte Elastase (HLE) Inhibitors.

J. Kofron, D. Hlasta, R. P. Farrell, 1996 .

Alkoxy substituted benzisothiazolone (BIT) derivatives: potent inhibitors of human leukocyte elastase

R. Gordon, D. Hlasta, E. Ferguson, 1995 .

Biological activity of WIN 63759, an orally bioavailable inhibitor of human neutrophil elastase

D. Hlasta, A. Maycock, J. Newton, 1995 .

Phosphonates and phosphinates: novel leaving groups for benzisothiazolone inhibitors of human leukocyte elastase.

R. Gordon, D. Hlasta, E. Ferguson, 1995, Journal of medicinal chemistry.

A benzisothiazolone class of potent, selective mechanism-based inhibitors of human leukocyte elastase

D. Hlasta, M. Bell, J. Court, 1994 .